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ABSTRACT

Background: Brain health diplomacy aims to inﬂuence the global policy environment for brain health (i.e.
dementia, depression, and other mind/brain disorders) and bridges the disciplines of global brain health,
international affairs, management, law, and economics. Determinants of brain health include educational
attainment, diet, access to health care, physical activity, social support, and environmental exposures, as well as
chronic brain disorders and treatment. Global challenges associated with these determinants include
large-scale conﬂicts and consequent mass migration, chemical contaminants, air quality, socioeconomic status,
climate change, and global population aging. Given the rapidly advancing technological innovations impacting
brain health, it is paramount to optimize the beneﬁts and mitigate the drawbacks of such technologies.
Objective: We propose a working model of Brain health INnovation Diplomacy (BIND).
Methods: We prepared a selective review using literature searches of studies pertaining to brain health
technological innovation and diplomacy.
Results: BIND aims to improve global brain health outcomes by leveraging technological innovation, entrepreneurship, and innovation diplomacy. It acknowledges the key role that technology, entrepreneurship,
and digitization play and will increasingly play in the future of brain health for individuals and societies alike.
It strengthens the positive role of novel solutions, recognizes and works to manage both real and potential risks
Correspondence should be addressed to: Dr Harris Eyre, MBBS, PhD, Innovation Institute, Texas Medical Center, Suite X, 2450 Holcombe Blvd, Houston, Texas,
77006, USA. Email: harris.eyre@gmail.com. Received 09 Oct 2019; revision requested 27 Nov 2019; revised version received 09 Dec 2019; accepted 21 Dec 2019.
* The views expressed in this paper are those of the authors and not necessarily of the authors’ organizations including the U.S. Administration on Aging/
Administration for Community Living, U.S. Department of Health and Human Services.
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of digital platforms. It is recognition of the political, ethical, cultural, and economic inﬂuences that brain health
technological innovation and entrepreneurship can have.
Conclusions: By creating a framework for BIND, we can use this to ensure a systematic model for the use of
technology to optimize brain health.

Key words: Brain health, dementia, Alzheimer’s, technology, depression, innovation, diplomacy, entrepreneurship

Introduction
Health diplomacy focuses on negotiations that aim
to inﬂuence and affect the global policy environment
for human health and it leverages the disciplines of
global health, international affairs, management,
law, and economics (Kennedy et al., 2017; Turekian
et al., 2014; WHO, 2018). Health diplomacy uses
conventional approaches to optimizing global health
such as strengthening the health system and leveraging the public and not-for-proﬁt sectors. It is an
important means of exercising large-scale reforms
because it can have cultural and economic impact on
many nations. There have been numerous examples
of health diplomacy making important contributions
to solving global health care crises (e.g. the President’s Emergency Plan for AIDS Relief [PEPFAR];
projects addressing Ebola and Zika viruses, the “bird
ﬂu” and “swine ﬂu” epidemics, the rise of antimicrobial resistance; and the Sustainable Development
Goals aiming to impact chronic disease deaths
(Colglazier, 2018; Gomez-Olive and Thorogood,
2018; Reid et al., 2019)).
The population of people with illnesses affecting
brain health (i.e. dementia, depression, and other
mind/brain disorders) is increasing rapidly around
the world (ADI, 2018; Cantarero-Prieto et al., 2019).
The global societal and economic cost of dementia is
approximately USD $1 trillion per year (ADI, 2018).
Rates of dementia and their associated economic
burden are both growing (ADI, 2015; 2018;
Cantarero-Prieto et al., 2019). While dementia is
not a normal part of the aging process, advanced age
remains a primary risk factor. In the coming decades, expansion of aging populations will occur most
rapidly in low- and middle-income countries (LMICs
[Parra et al., 2018]). Therefore, the burden of
dementia will be disproportionately experienced in
these regions (ADI, 2013; GBHI, 2019; UN, 2015).
Dementia incidence is driven largely by the same
determinants that drive other major health conditions
that are rooted in socioeconomic inequities such as
lower educational attainment, poor diet, smoking,
less access to health care, and inadequate treatment of
hypertension and other medical diseases (GBHI,
2019; Livingston et al., 2017; Sukumaran, 2019).
Alarmingly, few countries have developed a national
dementia plan, dementia still is often assumed to be

a normal part of aging and is often underrecognized
(GBHI, 2019; Livingston et al., 2017; Valcour et al.,
2000). The World Health Organization (WHO) has
set a target of 75% of all member states (or 146
countries) to have a national plan on dementia in
place by 2025 (WHO, 2017). As of 2019, only 32
countries had implemented a plan (ADI, 2019).
These 32 adopters tend to be high-income countries
(HICs) such as Australia, Japan, Norway, and the
U.S., although Mexico, Cuba, and Indonesia all
have national plans for dementia. Another 30 countries have plans under development, which would
result in a much broader global reach once implemented (Barbarino et al., 2019).
Epidemiological modeling demonstrates that a
population-level dementia risk reduction approach
of 10–20% could prevent up to 8–15% of dementia
cases projected around the world, respectively, in
the next 20 years (Norton et al., 2014). Additionally,
individual-level factors such as access to medicine
and information, neuroimaging, diagnostics, specialist care, and personal beliefs associated with brain
health can have a signiﬁcant impact on personal wellbeing. Further, higher-level determinants – e.g. air
pollution and conﬂict-driven mass migration – may
impact disease course by hastening disease onset
(Peters et al., 2019) or preventing access to care
(Ledoux et al., 2018), respectively. Current global
challenges that may be exacerbating population
brain health disorders include climate change, air
pollution, large-scale conﬂicts and associated mass
migration, food insecurity, and lost productivity due
to communicable and noncommunicable health
conditions (for reviews, see Carey et al., 2018; Chen
et al., 2017; Jung et al., 2015; Killin et al., 2016; Ledoux
et al., 2018; Livingston et al., 2017; Wei et al., 2019).
Given the breadth of factors that affect brain health,
large-scale diplomatic activity is necessary to improve
such societal conditions. These activities will help
to coordinate and enhance projects in research,
advocacy, clinical care, and public health across
the globe HICs and LMICs.
We propose these traditional health diplomacy
approaches to brain health should be referred to as
“brain health diplomacy.” We hereby propose that
brain health diplomacy will inﬂuence the global
policy environment for brain health by leveraging
the disciplines of global brain health, international

Downloaded from https://www.cambridge.org/core. Portland State Library, on 21 Jul 2020 at 22:41:47, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
https://doi.org/10.1017/S1041610219002266

Brain health INnovation Diplomacy

affairs, management, law, and economics. Key
examples of brain health diplomacy approaches
include the WHO Guidelines titled “Risk Reduction
of Cognitive Decline and Dementia” (WHO, 2019a),
The Lancet’s Commission on Dementia Prevention,
Intervention and Care (Livingston et al., 2017), and
The Lancet-World Psychiatric Association Commission on Depression (Herrman et al., 2019). Such
approaches aim to provide equity care and outcomes
for dementia risk reduction and care in LMICs and
HICs, as well as to save costs.
The current ﬁeld of brain health diplomacy is
valuable but, as it is, will not likely make a big enough
impact on global brain health outcomes. It does not
adequately consider the growing importance of technological innovation and entrepreneurship. Technological innovation and entrepreneurship may augment
the impact of conventional brain health diplomacy
mechanisms. With increasing rates of technological
ubiquity, decreasing costs, and rapidity of innovation, the impact of technology on society is more
visible than ever. The World Economic Forum (WEF)
has conceptualized a Fourth Industrial Revolution
as a model for articulating the disintegration of
boundaries among the physical, digital, and biological worlds (WEF, 2019). It signiﬁes the merging of
infotech, biotech, robotics, 3D printing, artiﬁcial
intelligence (AI), the Internet of Things (IoT), genetic
engineering, omics, quantum computing, and other
deep technologies.
In the domain of brain health, technological
innovation is the application of technologies to brain
health services and solutions using, for example,
biomarkers and genomics, personal computing
devices such as smartphones and tablets, computerized neurocognitive assessment systems, wearable
monitors, web-based psychosocial and self-help
resources, telehealth, multimodal neuroimaging,
AI, virtual reality, and augmented reality (Abbott
et al., 2018; Eyre et al., 2015a, 2017, 2018; Knapp
et al., 2015; NSTC, 2019).
The model on Brain health INnovation Diplomacy (BIND) proposed is adapted from the
previously proposed model of Mental Health Innovation Diplomacy (Eyre et al., 2019). BIND aims to
improve global brain health outcomes by leveraging
technological innovation, entrepreneurship, and
innovation diplomacy. Improving outcomes may
arise from optimization of access to care, prevention,
screening, diagnosis, treatment, and treatment outcome tracking. BIND broadens the scope of health
diplomacy by bringing together (or bind aka
“BIND”) the disciplines of brain health, health
diplomacy, and science diplomacy with the emerging disciplines of precision medicine, digital health,
convergence science, innovation diplomacy, technology diplomacy, implementation science, and

3

consumer participation. Each of these disciplines
provides critical input to the ﬁeld of BIND, but
none alone are sufﬁcient. Here, we offer current
examples of BIND in action and provide further
recommendations to develop the ﬁeld.
In this paper, mental health and brain health are
distinctly different ﬁelds. Mental health focuses on
mental health disorders (e.g. depression, schizophrenia, attention deﬁcit hyperactivity disorder), and brain
health focuses on neurodegenerative disorders such as
dementia and other cognitive disorders. There is ever
greater convergence of these areas as the biological
basis of mental disorders is increasingly deﬁned.

Review of the role of technology and innovation
in global health, brain health, and aging
If the model of BIND proposes to manage the
promise and perils of technological in brain health,
it is important to ﬁrst review the role technology in
this context. In the sections below, we explore the
role of technology in global health, brain health, and
aging contexts. We explore the role of technologies
such as social media, internet use, remote monitoring sensors, and conclude by considering ethics.
Prototypes of innovations and innovation
ecosystems inﬂuencing global health
There are a number of examples of speciﬁc innovations and innovation ecosystems serving to address
neglected global disease and health conditions with
new health technologies (Juma, 2018; Staruch et al.,
2018). These examples are illustrative and could be
adapted or leveraged for brain health innovation.
One example is the provision and use of low-cost
tablet computers like “Aakash” which was developed by Datawind and the Government of India and
sold to Indian university students for USD $35 with
the intention of reaching rural communities via
e-learning (Staruch et al., 2018). Such low-cost
computers have the potential to optimize the completion and sharing of medical records to better
coordinate care for displaced peoples who are
migrating across countries. They are also platforms
for digital health resources, among other uses.
Supporting global health technology development
is the newly established Global Health Technologies
Coalition (GHTC) (GHTC, 2019). The GHTC is an
advocacy organization, funded by the Bill and Melinda
Gates Foundation, focused on global health, research,
and development for new tools and technologies. The
coalition of more than 25 nonproﬁt organizations,
academic institutions, and aligned businesses advances
policies to accelerate the creation of new drugs,
vaccines, diagnostics, and other tools. The GHTC
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educates policymakers and stakeholders and convenes members and partners to facilitate innovation
and advocacy for policy solutions and investment to
spur innovation. This may be a useful platform for
brain health innovation.
A recent review explored the role of health diplomacy through health entrepreneurship and using
hackathons to address Palestinian-Israeli health concerns (Ramadi et al., 2019). Speciﬁcally, a hackathon was organized in Nazareth, Israel, supported
in partnership by MIT’s Hacking Medicine and
Hasoub, a local nonproﬁt. The authors noted
“Bringing together Arab-Israeli and Jewish stakeholders,
key academic and industry ﬁgures along with governmental agencies, the event bridged cultural lines and
created an open forum to allow participants to network
with large organisations, which could help move their ideas
forward. Importantly, participants were exposed to health
innovation methodologies and received the opportunity to
learn, build diverse teams and create solutions to health
problems” (page 6). This may be a useful predicate for
approaches to optimizing brain health outcomes and
cross-cultural understandings via hackathons.
Clinical brain health innovation in action
There are several areas of demonstrated clinical
value for brain health technologies (Lund et al.,
2018). A recent review was published by members
of the U.S. Alzheimer’s Association Technology
Professional Interest Area (Astell, 2019). There
are three broad categories:
• Dementia risk reduction technologies: Technology
can be used to address lifestyle-based dementia risk
reduction factors (Hartin et al., 2016). For example,
a recent meta-analysis of web-based multidomain
lifestyle programs for brain health (targeting physical and cognitive activities) demonstrated that these
programs can positively inﬂuence brain health outcomes (Wesselman et al., 2019).
• In-home remote monitoring and care for individuals
diagnosed with dementia: The provision of technologies such as apps, wearables, and smart home
systems could allow clinicians to remotely monitor
patients, hence reducing unnecessary outpatient
and inpatient visits. Such technologies can also
provide prompts to support maintenance of cognitive, social, and physical functioning as well as
tracking completion of daily activities.
• Technological solutions for dementia caregivers:
An illustrative example is the Supporting Family
Caregivers with Technology for Dementia Home
Care (FamTechCare) intervention (Williams
et al., 2018). As stated, this intervention provides
individualized dementia-care strategies to in-home
caregivers based on video recordings that the caregiver creates of complex and challenging care
situations (Williams et al., 2018). A team of
dementia care experts review videos submitted by

caregivers and provide interventions to improve care
weekly for the experimental group.

A recent British dementia technology report with
additional health economic analysis revealed dementia
technology would be cost effective from a health and
social care perspective in two core scenarios: postponing care home admission by at least 3 months and
reducing unpaid care hours by about 8% or improved
carer quality of life by 0.06 to 0.08 Quality Adjusted
Life Years (QALYs) per year (Knapp et al., 2015).
Investment into the brain health innovation
industry appears to be increasing (SharpBrains,
2013), yet some technology may be advancing without clear theoretical frameworks, awareness of ethical and privacy considerations, and without proof of
concept. This is not to say that technology should
not be part of the solution, but rather development
and scaling should proceed with caution.
Clinical aging innovation in action
A report from the Task Force on Research and
Development for Technology to Support Aging
Adults, White House National Science and Technology Council (NSTC, 2019) was recently released
seeking to convene U.S. federal government experts
to identify emerging technologies to meet the needs
of older adults. The report identiﬁed “a range of
emerging technologies that have signiﬁcant potential to
assist older adults with successfully aging in place, each
categorized by their role in supporting a set of primary
capabilities” (page 2). These emerging technology
areas included nutrition, hygiene, medication management, cognition, ﬁnancial security, hearing, and
telehealth. The report then provided recommendations as a guide for research and development.
The risk of adverse drug reactions and events is
correlated to old age, complex comorbidities,
dementia, and frailty, with the major contributor
being polypharmacy (Mangin et al., 2018). Each
characteristic alters the risk–beneﬁt balance of
medications, typically reducing anticipated beneﬁts and amplifying risk (Mangin et al., 2018).
Pharmacogenetic-based clinical decision support
tools (DSTs) may offer value for polypharmacy
reduction in old age, hence decreases hospitalizations and emergency department attendances
(Abbott et al., 2018; Chang et al., 2018).
Effects of computer and internet use on brain
health
Internet access has been designated a human right
by the United Nations (United Nations General
Assembly, 2016). Access to the internet, particularly broadband internet, has signiﬁcant potential
impacts on health outcomes for persons living
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with dementia and the brain health of aging adults.
However, with the rising number of older adults
using the internet has come increasing rates of
cybercrime and digital exploitation (Iyengar
et al., 2019).
The myriad ways that new health technologies
can promote better outcomes and innovative care
require this platform in order to reach people. While
internet utilization among older adults may be
driven by education, income level, and other social
determinants, internet access is also greatly impacted
by these same variables (PRC, 2014). Geography also
plays a role in access. Older populations with high
disease burdens living in rural areas are particularly
at-risk of lacking reliable internet access. The U.S.
Federal Communications Commission (FCC)
tracks broadband access and prevalence of chronic
health conditions such as diabetes and obesity – the
so-called “double burden” (FCC, 2017). Their
geomapping of these overlapping characteristics
demonstrates the stark inequality that exists. A
lack of internet access – particularly broadband
internet – undermines the very platform needed
to run and access new technological innovations,
which in turn limits the opportunity to receive care,
support, and education that technological innovations offer. Ensuring internet access is widely accessible to all persons as they age is a key step in
promoting health innovation and health equity.
Internet use has a number of recognized brain
health beneﬁts, including reducing depression,
increased health literacy, and increased social
engagement, particularly in advanced age (Choi
and Dinitto, 2013; Shim et al., 2018). In the past,
older adults who used computers regularly were
often white, better educated, and wealthier. However, those demographics are changing. A recent
study examining the effects of computer use in older
adults in and out of the home (e.g. libraries, friend’s
homes) found that those who access computers from
social resources were more likely to report higher
self-efﬁcacy and better self-reported health (Shim
et al., 2018). Compared to occasional or never users,
regular computer users reported higher self-efﬁcacy,
indicating that computer and internet access are
associated with more positive views of self by older
adults (Cacioppo and Hawkley, 2009). A large study
has suggested that self-reported craft activities in late
life, and social activities, game playing, and computer use in combined late-life and midlife stages
were all linked to a decreased incidence of mild
cognitive impairment (MCI) (Krell-Roesch et al.,
2019). In late life, a decreased risk of MCI was tied
to reading books, playing games, or engaging in
craft or social activities at least 2–3 times a month,
or using a computer at least 5–6 times a week
(Krell-Roesch et al., 2019). Interestingly, only
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computer use was associated with a signiﬁcantly
decreased risk of developing MCI regardless of
when in life computer use was reported (late-life,
midlife, or both) (Krell-Roesch et al., 2019).
Internet assessment of brain health and cognitive
assessment are growing. The Brain Health Registry
(Weiner et al., 2018) uses online strategies to assess
cognitive function and refer potential participants to
clinical trials. The Alzheimer Prevention Trial (APT)
web study uses similar approaches to online assessment with the goal of referring cognitively normal
persons to clinical trials for the prevention of AD. The
Cleveland Clinic’s healthybrains.org website provides a Brain Heath Index (BHI) based on six pillars
of brain health to guide users to more brain-healthy
lifestyles (Zhong and Cummings, 2016).
The negative implications of internet usage by
older adults is discussed later in this paper.
Social media use and brain health
Social media platforms may have a positive effect by
promoting interpersonal connectedness (Boll and
Brune, 2016). Numerous studies show that loneliness and social isolation can negatively impact overall health in older adults (Landeiro et al., 2017).
Social media platforms such as Facebook and Twitter are known to enhance social connectedness, and
a recent Pew Research report showed that about
one-third of all adults over age 65 reported using
them (Anderson and Perrin, 2017). Given the established relationship between the frequency of supportive interactions with others and the delayed onset
of cognitive decline, there are hypotheses that social
media may be protective against some forms of
dementia (Seeman et al., 2001), although reverse
causation may be occurring. A 2018, 34-person, waitlist control trial demonstrated that teaching older
adults to use social media improved their executive
functioning signiﬁcantly as measured by their inhibitory control and improved their overall cognition as
measured by the Mini-Mental State Examination
(MMSE) compared to controls. These data suggested
that social media may have impacts on brain health
beyond those of social and emotional connection
(Quinn, 2018). However, it should be noted that these
study ﬁndings are limited by a small sample size, a
nonstatistically signiﬁcant improvement in MMSE
between baseline and 4 weeks, and a short follow-up
period. The study did demonstrate that older adults
are capable of effectively learning how to operate these
newer technologies given the opportunity to do so, a
ﬁnding echoed in a 2015 randomized controlled
trial assessing the feasibility of using direct to
home daily video chats to evaluate for an increase in
social engagement in older adults without dementia
(Dodge et al., 2015). Not only did the intervention
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group show greater improvement in tests of
language-based executive functions, but adherence
in the intervention group was remarkably high: there
were no dropouts and the mean percentage of days
completed in the 6-week trial was 89% (Dodge et al.,
2015). It is an impressive statistic considering the
average age of participants was 80.5 years. The chat
software used did not require prior knowledge of
how to operate a computer (Dodge et al., 2015).
Alternatively, however, social media may have
adverse effects for older adults. Loneliness and
social isolation can dramatically alter cognitive
performance, decision making, and emotional
regulation (Cacioppo and Hawkley, 2009). Lonely
adults have more difﬁculty maintaining vigilance
and self-regulating and demonstrate a heightened
awareness of social threats, as well as paying greater
attention to negative social stimuli (Cacioppo and
Hawkley, 2009; Hawkley and Cacioppo, 2010).
This broad constellation of behaviors likely predisposes older, lonely adults to gravitate toward information on social media that mirrors their own
worldview, a trend ampliﬁed further by the algorithms of social media platforms that are constructed
to keep users on the platforms as long as possible, by
showing users content they are most likely to agree
with and enjoy. These ideas could explain recent
reports showing that individuals over age 65 are
seven times more likely to share and disseminate
fake news domains on social media than their younger counterparts (Guess et al., 2019). These results
are particularly concerning given the increased
numbers of aging adults on social media and the
fact that political and policy decisions are now often
shaped by information publicly available on these
platforms. Furthermore, other ﬁndings from Guess
et al. (2019) suggest that “memory and other cognitive
domains deteriorate in some elders in a way that particularly undermines resistance to ‘illusions of truth’ and
other effects related to belief persistence and the availability heuristic, especially in relation to source cues
(Glisky et al., 2001; Swire et al., 2017)” (page 5).
The severity of these issues would hypothetically
increase with the prevalence of misinformation
and the complexity of the information. This wealth
of data demonstrates the overwhelming interest in
social media as an inﬂuential technological tool of
our society and its potential for both therapeutic and
negative effects. More research and monitoring are
needed to strike an optimal balance. The difﬁculty of
balancing protected free speech and protection from
negative effects of social media is an ongoing debate.
Finally, the role of social media in optimizing
sociability is nuanced. A recent review (Waytz and
Gray, 2018) suggests social media can inﬂuence sociability in 3 core ways and these depend on whether it
allows a deeper understanding of peoples’ thoughts

and feelings. The suggestion is that social media “(a)
beneﬁts sociability when it complements already deep ofﬂine
engagement with others, (b) impairs sociability when it
supplants deeper ofﬂine engagement for superﬁcial online
engagement and (c) enhanced sociability when deep ofﬂine
engagement is otherwise difﬁcult to attain”. Clearly further
exploration of this issue is needed.
Ethical considerations in brain health
technological innovation
New and potentially valuable technologies that are
targeted toward improving the lives of either patients
or caregivers include memory and communication
aids, global positioning satellites (GPS) tracking
devices, “smart home” technologies, and even companion robots (Landau and Werner, 2012; Majumder
et al., 2017; Shibata and Wada, 2011). Although the
goals of these technologies have been positive, such as
aiming to delay entry into institutionalized care and
reduce caregiver burden, the ethical implications of
such technologies are only beginning to be studied.
Little consideration has been given to how these
technologies should be regulated in order to be compliant with human rights obligations or how they
should be incorporated into advance care planning
while an individual may still have decision-making
capacity (Bennett et al., 2017). Although many
assistive technologies were developed as a response
to the traditionally restrictive means of dementia
care (i.e. restraints, medication), these technologies
may provide new and unprecedented levels of surveillance, privacy limitation, and movement restriction (Bennett et al., 2017). Even the use of care or
companion robots has ethical considerations beyond
the obvious beneﬁts of caregiver unburdening, some
have argued these robots may eventually devalue
care and reduce person-to-person contact with older
adults, which would restrict rather than enhance
social interaction (Elder, 2015). Furthermore, there
are philosophical, ethical, and policy considerations
that deserve thoughtful attention when developing
assistive technologies for those with dementia
(Sharkey and Sharkey, 2012) – how can we balance
the need for safety and monitoring against the
potential feelings of objectiﬁcation and lack of
control? Is there an element of deception and infantilization created in addition to the potential loss of
privacy and personal liberties when technology is
responsible for caring and monitoring a human?
Are there circumstances under which a person living
with dementia should be able to control their own
devices?
With middle aged and older adults being among
the fastest growing demographics creating social
media proﬁles, ethical issues will undoubtedly arise
in concurrence with the pending dementia epidemic
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(Batchelor et al., 2012). Although the older adults
may be registering for proﬁles while they still have
capacity to accept the terms and conditions of a social
media account, what happens when they develop
dementia and no longer understand the far-reaching
implications of their digital footprint (Batchelor et al.,
2012)? How can we support digital autonomy while
also protecting privacy? Clearly, there is a need to
develop and integrate emerging ethicolegal frameworks into new technologies and innovation diplomacy in order to protect and promote brain health in
the most vulnerable populations.
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Traditional Disciplines
Health
Diplomacy

Global Brain
Health

Science
Diplomacy

Brain health INnovation Diplomacy
(BIND)
Aims to improve global brain health outcomes by
leveraging technological innovation, entrepreneurship
and innovation diplomacy.
Convergence
Digital Medicine
Medicine
Precision
Medicine

Technology
Diplomacy

Consumer
Participation

Innovation
Diplomacy

Emerging Disciplines

Introducing the BIND model
BIND aims to improve global brain health outcomes
by leveraging technological innovation, entrepreneurship, and innovation diplomacy. Improving
outcomes may arise from optimization of access to
care, prevention, screening, diagnosis, treatment,
and treatment outcome tracking. It acknowledges
the key role that technology, entrepreneurship, and
digitization will play now and in the future of brain
health for individuals and societies alike. It strengthens the positive role of novel solutions (e.g. “omics,”
neuroimaging, digital tools, sensors, internet-based
platforms, virtual reality, and augmented reality)
and recognizes and works to manage the potential
and real risks of digital platforms. It also recognizes
the political, cultural, and economic inﬂuences that
brain health technological innovation and entrepreneurship has in the 21st century.
Economic inﬂuence is derived from direct investment into brain health-related technologies. It is also
derived from the recognition of the economic and
productivity impact of brain health disorders. Cultural inﬂuences may emerge and develop as BIND
advocates for enhanced brain health care equity,
destigmatization, and socioeconomic inclusion for
people with brain health issues. In addition, human
rights violations, e.g. force restraints, physical and
sexual violence, and torture (in community or institutional settings in LMICs or HICs), may be
reduced with greater awareness and education
around brain health. With a greater engagement
of the private sector and trade and investment linkages for global brain health innovation, avenues for
cross-cultural understanding and improvement of
brain health care will be scaled up. Figure 1 provides
a graphical representation of the model.
Traditional disciplines of brain health
diplomacy
Brain health diplomacy draws insights from the
disciplines of global brain health, health diplomacy

Figure 1. Foundational Disciplines of Brain health INnovation
Diplomacy. BIND aims to improve global brain health outcomes
by leveraging technological innovation, entrepreneurship, and
innovation diplomacy. BIND incorporates insights from traditional
as well as emerging disciplines.

and science diplomacy. Below we provide a summary of these disciplines and describe frameworks
for developing practitioners in these ﬁelds.
SCIENCE DIPLOMACY
Science diplomacy is a ﬁeld which uses science as an
instrument to achieve foreign policy objectives that
serve to promote peace, sustainable development
and ethical research. It leverages “science” as a
process and way of communicating, as well as the
research outcomes (UNESCO, 2018).
A major source of capacity building for science
diplomacy was established in 2008, when the American Association for the Advancement of Science
established the Center for Science Diplomacy
(AAAS, 2020). The Center is a leader in positioning
science diplomacy as a key aspect of 21st century
science and international affairs. The Center has
strengthened engagements between the scientiﬁc
and diplomatic communities and developed the
framework and training to support the practice of
science diplomacy. Importantly, it has shown how
science can work to strengthen relationships
between countries when geopolitical strains are
apparent. A range of education and capacitybuilding programs for early career academic innovators are outlined by Holford and Nichols (2018).
HEALTH DIPLOMACY
Health diplomacy is a ﬁeld that merges the disciplines of public health, management, international
affairs, economics, and law, with a focus on negotiations that impact the global public health policy
(WHO, 2018).
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There are three levels of health diplomacy that
have been formally postulated, as “core”, “multistakeholder”, and “informal” (Brown et al., 2014;
Katz et al., 2011). Each level has varying actors,
tools, roles, and levels of accreditation.
• “Core” health diplomacy practitioners are ofﬁcially
accredited “Health Attachés” charged with connecting public health organizations in one government
to public health and related organizations in another
government (e.g. departments of innovation, science, industry, aging, trade and investment, and
social services). “Health Attachés” require formal
credentialing which involves obtaining agreements
between two state Foreign Affairs Ministries.
• “Multi-stakeholder” health diplomacy practitioners
include government employees and multilateral
representatives.
• “Informal” health diplomacy includes host country
ofﬁcials as well as a wide array of other stakeholders
including universities, non-governmental organizations, private enterprises, and the general public.

GLOBAL BRAIN HEALTH
Global brain health aims to protect the global aging
populations from risks and threats to brain health
(e.g. dementia and stroke) (AARP, 2019; GBHI,
2019). The ﬁeld aims to collaborate in developing
and expanding preventions and interventions, share
knowledge and engage in advocacy for all of the
major neurodegenerative disorders of late life.
In 2019, the AARP (formerly known as the American Association of Retired Persons) established
the Global Council on Brain Health (GCBH). The
GCBH is an independent collaborative, created to
provide trusted information on how individuals can
maintain and improve their brain health (AARP,
2019). The GCBH states a primary goal of supporting consumers to apply the latest scientiﬁc advances
to boost their brain health and optimize their quality
of life.

Emerging disciplines informing BIND
With the growth of technological innovation and
entrepreneurship in brain health there is a need to
incorporate emerging disciplines into standard
working models that are adapted to address the
likely brain health challenges in the 21st century.
An overview of these emerging disciplines is presented below.
PRECISION MEDICINE
The clinical neurosciences have been transformed
by embracing precision medicine and systems
biology. Leveraging such models has helped
to facilitate novel care solutions for proteinopathies, neurodegenerative disease (such as AD),

protein misfolding disorders, and other dementias
(Hampel et al., 2018). Development of treatments
targeted to the needs of speciﬁc individuals are
conceived on the basis of technologies using
“multi-omics” inputs from genomics, epigenomics,
connectomics, lipidomics, proteomics, metabolomics, digitomics, and phenomics. These new
treatments may include novel drug compounds,
pharmacogenomic strategies, or other companion
diagnostics (such as neuroimaging biomarkers)
(Hampel et al., 2018). Such strategies also help to
illuminate novel pathophysiological mechanisms
and help reﬁne staging and classiﬁcation of disease.
(Hampel et al., 2018). This discipline is of course
most relevant in HICs, as opposed to LMICs.
DIGITAL HEALTH
Digital health describes a ﬁeld that leverages digital
technologies (e.g. hardware and software) as tools
for optimizing screening, diagnostics, treatment,
and prevention of health disorders (DMS, 2019).
Digital technologies may assist in driving efﬁciencies
within the health care ecosystem (e.g. in various
settings including inpatient, outpatient, home, and
community) (Coravos et al., 2019).
Digital health solutions can be used stand alone
or in “companion” with pharmaceuticals, biologics,
devices, or other products. Digital health facilitates patient and health care provider empowerment with data and can be used in public health/
epidemiological projects. Digital biomarkers aka
“digitomics” can be examined in parallel with other
biological, environmental, and lifestyle factors to
deliver previously unavailable insights into disease
states, their development, and treatment.
CONVERGENCE MEDICINE
Convergence science in medicine, ala convergence
medicine, involves leveraging convergence or transdisciplinary science in order to achieve improved
outcomes for patients and health care systems. This
means robust integration of scientists, clinicians,
bioinformaticists, global health experts, engineers,
technology entrepreneurs, medical educators, caregivers, and patients (Eyre et al., 2015b; Eyre et al.,
2017). Convergence medicine will be realized when
there is an abundance of clinical tools in use leveraging convergence science.
INNOVATION DIPLOMACY
Innovation diplomacy involves the use of diplomacy
to further innovation for a country, as well as
leveraging innovation to improve the relations
among countries in bi-, multi-, or transnational
settings (Miremadi, 2016). Innovation diplomacy
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includes supporting partnerships with industry,
academic, and nongovernmental organizations; supporting open innovation and collaboration; shaping
intellectual property rights, ethical regulation, and
use of technology; structuring global value chains;
as well as developing, deploying, and scaling innovative solutions to global problems (Leijten, 2017).
These practices sit somewhere between science
diplomacy (mentioned previously) and economic
diplomacy, which focus on trade, investment, and
international regulations (Leijten, 2017).
TECHNOLOGY DIPLOMACY
Technology diplomacy acknowledges “the key
role that technology and digitalization will play
now and in the future for individuals and societies
alike and notes the tech industry’s political and
global inﬂuence” (Udenrigsministeriet, 2019).
The “TechPlomacy Initiative,” launched by the
Danish government in 2017, suggests “technology
will contribute to solving some of the most acute global
challenges and bring about a positive transformation
with enormous potential for people around the world”
(Udenrigsministeriet, 2019).
The Danish government established a “Tech
Ambassador” Ofﬁce between Silicon Valley (California, USA), Copenhagen (Denmark), and Beijing
(China) (Udenrigsministeriet, 2019). With a global
mandate to rethink traditional diplomatic representation, the Tech Ambassador functions to develop
strategic partnerships with entrepreneurs and
executives, tech ecosystems and hubs, biotechnology
organizations, governments, international organizations, civil society, cities, regions, and universities.
Relevant initiatives include security, cyber, biotechnology, development, export, and investment promotion. Opportunities and challenges arising with
this technology agenda are then also addressed in
relevant and complementary bi-, multi-, and transnational fora.
CONSUMER PARTICIPATION
Consumer participation is a contemporary approach
and may take place through research, policy, ethics
discussions, clinical care, or novel solution development. Indeed, consumers are already involved in
managing their own health through the use of smart
devices, the internet as a source of information, and
social networks to share ideas and organize (Sagner
et al., 2017).
A key outcome for the brain health ﬁeld is novel
solution development that appropriately focuses on
end user needs by incorporating consumer contributions to both product design as well as testing. Validation of new technologies prior to their
implementation can be difﬁcult through current
research practices; however, consumers can help

9

expand research practices by identifying the highestpriority questions to answer, advocating for necessary
resources, and inﬂuencing the design of models for
joint clinical decision making. As both research subjects and the ultimate beneﬁciaries or users of new
technologies, consumers also have a critical perspective on ethical issues unique to brain health.
A useful example of consumer participation comes
from the ﬁeld of bipolar disorders. Communitybased participatory research (CBPR) leverages the
lived experience of bipolar disorder, inviting consumers to act as coinvestigators rather than merely
test subjects. Research priorities are dictated by the
needs of the community, resulting in relevant, timely,
and applicable ﬁndings that reciprocally beneﬁt the
community by improving mental health literacy, treatment planning, treatment adherence, and stigma
reduction (Michalak et al., 2016).
Forums such as PatientsLikeMe are a repository
of health data shared by patients, enabling learning
from shared experiences, unlike generalized and
nonspeciﬁc information available on traditional
health information websites (PatientsLikeMe., 2017).
Online patient communities can facilitate screening
and recruitment of patients into studies, transcending
the conventional method that relies on treating clinicians. Not only is there a dataset that can be readily
accessed, this method may also offer greater study
exposure and more diverse sample populations. The
overarching message is that consumers can and do
contribute to research and that existing platforms can
be utilized to support the process.
Introducing a working model for the roles of
BIND practitioners
In this rapidly emerging ﬁeld, it is important to
conceptualize the toolkit for BIND practitioners.
Table 1 outlines roles relevant to BIND practitioners. These roles are developed from the realworld experiences of the authors, understandings of
the foundational disciplines of BIND, and use of
the adapted UK-based innovation foundation,
NESTA’s Innovation Toolkit for iDiplomats (Bound
and Saunders, 2018).
Examples of BIND projects
There is a range of existing projects that further the
goals of BIND and could be seen as useful models to
develop new programs in the future. These projects
are outlined in Table 2.
Complex technological issues justifying the
need for, and value of, BIND
There are a range of complex technology-related
issues which we believe justify the need for, and
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Table 1. Roles relevant to Brain health INnovation Diplomacy practitioners
EXPLORING AND ASSESSING

INFLUENCING AND

CULTIVATING AND

ADVOCATING AND

PROMOTING

CONNECTING

SUPPORTING

ACTIVATING AND SCALING

..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................

- Develop in-depth understanding of the host country’s brain
health clinical, science, and
innovation systems (statistical
data, tacit knowledge, rates of
stigma, horizon scanning,
social media-related issues,
etc.)
- Create real-time information
ﬂows back to one’s home
country on opportunities and
threats
- Identify and assess opportunities with respect to wider
stakeholders (that could help
one’s country leverage
strengths, achieve strategic
policy goals, gain access to
talent/facilities/funding for
innovation, etc.)

- Inﬂuence policies to
improve the wider
conditions for collaboration with innovative
home country companies, research institutes, brain health
systems (e.g. intellectual property regime,
market access)
- Encourage adoption of
one’s home country’s
models and systems for
supporting innovation
(e.g. standards)
- Promote the strengths
of the home country’s
health, research, and
innovation system,
creating demand for
collaboration
- Promote one’s home
country as a destination for foreign
technology-based
investments

- Build relationships with
decision-makers (policy,
funder, institution, large
enterprises)
- Design and run targeted
events and workshops to
spur new international
partnerships
- Organize missions and visits
to familiarize researchers and
companies with new
opportunities
- Match individuals/institutions/
companies with appropriate
international partners
- Channel and facilitate enquiries about one’s home country’s innovation system to the
appropriate institution/
individual

- Advocate for patients and
families especially when
working with policy and
funding decision-makers
- Understand the balance of
caregiving versus autonomy
in developing new assistive
technologies
- Consider ethicolegal implications for novel therapeutics and technologies and
whether they are patientcentric
- Support vulnerable populations and those that cannot
advocate for themselves
- Recognizing the importance
of engaging and incorporating the voice of the lived
experience (for people living
with dementia (PLWD),
their caregivers/care-partners
and direct care providers)

- Follow-up connections and encourage partnership development and best practice
collaboration
- Develop, codevelop, or identify external
resources to help secure and scale promising
collaborations (ﬁnance, advisory, etc.)
- Accelerate the commercialization of research
that could beneﬁt one’s home country
- Partner with other innovation support agents
of one’s home country to help them achieve
their international goals

Adapted from the UK-based innovation foundation, NESTA’s Innovation Toolkit for iDiplomats (Bound and Saunders, 2018). This adaptation involved modiﬁcation to frame relevant to brain health,
as well as the inclusion of “Advocating and Supporting” as a new category.

BRAIN HEALTH INNOVATION DIPLOMACY PROJECT

POTENTIAL MEASURABLE OUTCOMES

..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................

World Young Leaders in Dementia (www.wyldementia.org): The World Young Leaders in Dementia (WYLD) is
a network of passionate, young clinicians, researchers, advocates, artists, and entrepreneurs working across
disciplines and borders to develop innovative dementia solutions. Membership represents over 300
engaged individuals under the age of 40, covering 30 countries across six continents. WYLD emerged
from a series of legacy meetings following the 2013 G8 Dementia summit. The UK Science & Innovation
Network invited emerging leaders working in diverse fields of dementia to meet at events held in Ottawa,
Tokyo, Washington DC, and London. In March 2015, a draft a set of proposals was presented at WHO’s
First Ministerial Conference on Global Action Against Dementia. This process sparked a number of new
research collaborations and creation of the WYLD network. Together, WYLD will create a better world
for those living with dementia, their families, and their communities. WYLD aims to do this by:
Bringing creative brainstorming, fresh perspectives, and novel solutions to the dementia field.
• Contributing to new dementia strategies that incorporate the latest innovations in technology and
research to meet the needs of a rapidly changing world.
• Providing a platform for idea exchange and shared projects to enable a culture of collaboration among the
next generation of leaders in dementia.

•
•
•
•
•

Centre for Aging and Brain Health Innovation (https://www.cabhi.com/): CABHI is a unique collaboration of
health care, science, industry, not-for-proﬁt and government partners whose aim is to help improve quality of
life for the world’s aging population, allowing older adults to age safely in the setting of their choice while
maintaining their cognitive, emotional, and physical well-being. The mission is to accelerate: development,
validation, commercialization, dissemination and adoption of innovative products, services and best
practices to support brain health and aging.

• Readership and utilization of guidelines for innovation and
•
•
•
•
•

entrepreneurship
Utilization of novel clinical tools
Academic outputs, e.g. papers, impact, conference presentations
Number of individuals trained in brain health entrepreneurship
Disciplines of trained individuals
Ecosystem scanning of accelerators and incubators supporting brain health innovation companies

USAgainstAlzheimer’s (https://www.usagainstalzheimers.org/): UsAgainstAlzheimer’s is an innovative nonproﬁt
organization demanding – and delivering – a solution to Alzheimer’s. Driven by the suffering of millions of
families, UsAgainstAlzheimer’s presses for greater urgency from government, industry, and the scientiﬁc
community in the quest for an Alzheimer’s cure—accomplishing this through effective leadership,
collaborative advocacy, and strategic investments.

•
•
•
•
•

Number of members
Number of innovative solutions developed
Contributions to innovative dementia strategies
Outputs of white papers and strategic documentation
Disciplines of trained individuals

Aging 2.0 (www.aging2.com): Aims to accelerate innovation to address the biggest challenges and opportunities
in aging. Aging 2.0’s international, interdisciplinary and intergenerational community has grown to 40 k +
innovators across 20 + countries. The volunteer-run chapter network, which spans 80 + cities, has hosted
more than 550 events around the world. Aging 2.0 is run by a team out of San Francisco, California and
Chapter Ambassadors in more than 80 cities around the globe.

•
•
•
•
•
•

Capital invested each year
Number of investment deals closed
Number of investment deals initiated
Type of companies receiving capital
Countries where invested companies are headquartered
Countries where invested companies are operating in the
market

Number of members
Number of innovative solutions developed
Contributions to innovative dementia strategies
Outputs of white papers and strategic documentation
Disciplines of trained individuals
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Table 2. Examples of Brain health INnovation Diplomacy projects

POTENTIAL MEASURABLE OUTCOMES

..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................

iSupport is the World Health Organization’s E-Programme for Carers of People Living with Dementia (WHO, 2019b):
It is an online knowledge and skills training program for carers of people with dementia. iSupport aims to
prevent and/or decrease mental and physical health problems associated with caregiving and to improve the
quality of life of those caring for people with dementia. iSupport covers the following topics:
• General information about dementia
• Information related to being a carer
• Self-care
• Providing care for the person with dementia
• Addressing symptoms of dementia

• Impact on burden of dementia
• Number of engagements globally on content

International Genomics of Alzheimer’s Project (IGAP) (https://consortiapedia.fastercures.org/consortia/igap/): The
aim of the IGAP consortium is to discover and map the genes that contribute to Alzheimer’s disease (AD).
The effort spans several consortia focused on AD and includes universities from Europe and the U.S. The
goal is to create a shared resource database that includes genetic data for the more than 40,000 individuals
with AD. Launched in 2011, initiating organizations include European Alzheimer Disease Initiative,
Alzheimer’s Disease Genetics Consortium, Genetic and Environmental Risk in Alzheimer’s Disease, and
Cohorts for Heart and Aging Research in Genomic Epidemiology

• Number of countries engaged
• Number of ethnicities included in scientiﬁc investigation

Mayo Clinic Neuroscience Convergence Course, November 7–9, 2019 (https://ce.mayo.edu/neurology-andneurologic-surgery/content/neuroscience-convergence-2019). This course has a number of core aims:
• Discuss complex neuroscientiﬁc conditions requiring a convergence science approach
• Identify emerging neuroscience innovations in clinical, basic science, and engineering
• Recognize and implement the concept of convergence as outlined by National Academies of Medicine,
Science and Engineering, National Institutes of Health, and how this helps translational science
• Identify opportunities for scientiﬁc collaboration, discovery, and problem solving
• Create a growing network of convergence neuroscience teams among basic scientists, neurologists,
neurosurgeons, engineers, and computing science (artiﬁcial intelligence and machine learning)

•
•
•
•
•

Global Brain Health Institute (GBHI) (www.gbhi.org): Funded by Atlantic Philanthropies and based between
the University of California, San Francisco and Trinity College Dublin, the GBHI works to reduce the scale
and impact of dementia around the world by training and supporting a new generation of leaders to translate
research evidence into effective policy and practice. Atlantic Fellows hail from all over the world and
comprise a diverse array of professions including medicine, law, business, social science, journalism, and the
arts. Examples of current and former Atlantic Fellows’ projects are as follows:
• Laura Booi PhD, Canada, gerontologist, founding member of the World Young Leaders in Dementia,
supporting dementia inclusive initiatives across Canada, participation in the development of Canada’s
ﬁrst national dementia strategy
• Walter Dawson, DPhil, USA, brain health policy expert, engaged in various public policy and digital
brain health projects across the USA that support earlier detection of cognitive impairment
• Agustin Ibanez PhD, Argentina, Neuroscientist, development of a platform to improve prevention,
diagnosis, and research of relevant cognitive disorders in Latin American countries, supported by the
NHI/NIA, and recently expanded by the Alzheimer’s Association, the Tau Consortium and the GBHI

• Number of individuals trained in brain health entrepreneurship,

Number of individuals trained in convergence neuroscience
Disciplines of trained individuals
Countries of residence of trained individuals
Countries where trained individuals are now operating
Numbers of foreign innovators visiting to learn from this model

innovation diplomacy, and innovation
Disciplines of trained individuals
Countries of residence of trained individuals
Countries where trained individuals are now operating
Ecosystem scanning of accelerators and incubators supporting
brain health innovation companies
• Numbers of foreign innovators visiting to learn from this
model

•
•
•
•
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Table 2. Continued

BRAIN HEALTH INNOVATION DIPLOMACY PROJECT

POTENTIAL MEASURABLE OUTCOMES

..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................

World Wide Fingers (http://wwﬁngers.com/): An interdisciplinary network to share experiences, harmonize data,
and plan joint international initiatives for the prevention of cognitive impairment/dementia. Its main goal is
to generate robust evidence to deﬁne effective preventive approaches for various at-risk groups and settings.
World Wide FINGERS will facilitate synergistic use of data from several countries, creating a unique
opportunity for rapid knowledge dissemination and implementation.

• Impact on burden of dementia
• Number of engagements globally on content
• Number of global sites of studies

Neuroscape (https://neuroscape.ucsf.edu/): A translational neuroscience center at University of California, San
Francisco involved in research and development of cutting-edge technologies to optimize brain assessment
and optimization. The center provides state-of-the-art development studios and research facilities to
transform neuroscience research into real-world solutions. Their mission is to use modern technology and a
wide range of industry partners to harness the brain’s plasticity to ultimately enhance cognition and improve
brain function. Neuroscape believes that partnerships with private companies serve as bridges between
academia and industry, with the goal of more rapidly accelerating advances in science, education, and
medicine.

• Readership and utilization of guidelines for innovation and
•
•
•
•
•

entrepreneurship
Utilization of novel clinical tools
Academic outputs, e.g. papers, impact, conference presentations
Number of individuals trained in brain health entrepreneurship
Disciplines of trained individuals
Ecosystem scanning of accelerators and incubators supporting
brain health innovation companies

Center for the Future of Aging, Milken Institute (https://www.milkeninstitute.org/centers/center-for-the-future-ofaging): The mission is to improve lives and strengthen societies through the promotion of health purposeful
aging and by:
• convening and partnering with inﬂuential decision makers and media leaders to change the perception
and motivate action.
• evaluating policies and practices, innovative models, and potential solutions to enhance health, wellbeing, and opportunity across the lifespan.
• advocating for change in the public and private sectors to ensure a better future for today’s older adults
and for generations to come.

•
•
•
•
•

Number of members
Number of innovative solutions developed
Contributions to innovative dementia strategies
Outputs of white papers and strategic documentation
Disciplines of trained individuals

The Global Council on Brain Health (GCBH), AARP and Age UK, (https://www.aarp.org/health/brain-health/
global-council-on-brain-health/about-us/): An independent collaborative of scientists, health professionals,
scholars, and policy experts from around the world working in areas of brain health related to human
cognition. GCBH will operate as a hub-and-spoke collaborative to address the many factors that can impact
brain health. Debate the latest advancements in brain health scientiﬁc research to reach consensus on what
works. Seek to translate critical scientiﬁc information on brain health into simple actions people can take.

• Outputs of white papers and strategic documentation
• Contributions to innovative dementia strategies

Dementia Discovery Fund (https://theddfund.com/): The world’s largest venture capitalist fund focused entirely
on developing and discovering new therapies for dementia. Over the 15-year life of the fund, there is a
mandate to validate novel hypotheses and expand the breadth of target mechanisms in dementia
development. The DDF has raised over £250 million while investing in diverse technologies targeted toward
new disease-modifying drugs and also attempting to meet other clinical needs such as relieving symptomatic
burdens of illness and improving quality of life.

•
•
•
•
•
•

Capital invested each year
Number of investment deals closed
Number of investment deals initiated
Type of companies receiving capital
Countries where invested companies are headquartered
Countries where invested companies are operating in the
market
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POTENTIAL MEASURABLE OUTCOMES
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BrainMind (https://www.brain-mind.org/): BrainMind is a platform and private community of brain scientists,
entrepreneurs, philanthropists, investors, and academic institutions dedicated to impactful innovation of
brain science. It seeks to coordinate talent from the entrepreneurial community with capital from the
philanthropic community to deliver stewardship of neuroscience to impact focused stakeholders. By using
the principles of “gather, curate, cultivate,” it brings together a powerful community of diverse and
motivated leaders interested in changing brain science to establish a roadmap for an effective way forward.
The platform recognizes areas in brain science research that are under supported relative to their impact and
provides high consciousness capital and leadership to grow and scale these innovations to ultimately beneﬁt
society.
KAER Toolkit from the Gerontological Society of America (http://www.geron.org/kaer): Focused on the KAER
model developed by the GSA Workgroup on Cognitive Impairment Detection and Earlier Diagnosis. The
workgroup identiﬁed valuable tools and resources to implement the four steps in the KAER model. The
resulting toolkit provides options for each of the steps so that primary care providers (PCPS), health plans,
and health care systems can select the approaches and tools that ﬁt best with their existing primary care
structure, organization, and procedures. The toolkit is broken down by each section of the KAER model to
allow quick and easy access:
• Kickstart the cognition conversation
• Assess for cognitive impairment
• Evaluate for dementia
• Refer for community resources

•
•
•
•
•
•

Capital invested each year
Number of investment deals closed
Number of investment deals initiated
Type of companies receiving capital
Number of innovative solutions developed
Contributions to innovative dementia strategies

•
•
•
•

Number of downloads and uses
Outcomes assessment of value of tool
Number of clinicians using
Repeat usage from clinicians and health care organizations

The McLean Technology and Aging Lab (http://www.geropsychtech.org): The Technology and Aging Lab at
McLean Hospital in Belmont, MA, is research and clinical unit focused exclusively on studying how newer
technologies can impact care for older adults with dementia and psychiatric illness. The lab studies both
digital diagnostics and therapeutics and its work spans multiple technological domains including artiﬁcial
intelligence, passive sensing, wearable devices, virtual reality, and wearable devices. The lab lays special
focus on the process of integrating technology into patient care and developing outcomes that can capture
how digital tools impact clinical decision making. In addition to its intramural activities, the lab conducts
collaborative research and consultation with companies and academic institutions around the world,
including projects in India, Norway, and Ecuador.

• Impact of technology on clinical care and treatment

The Oregon Center for Aging and Technology (ORCATECH; https://www.ohsu.edu/oregon-center-for-aging-andtechnology): Is a multidisciplinary organization that is transforming clinical research by developing and
implementing leading-edge technologies that measure life’s data in real time. ORCATECH specializes in:
Medical technology consultation, design, and development; Technology-based medical trial consultation
and coordination, from focus groups to ﬁeld-testing; high-resolution data handling and analysis.

• Readership and utilization of guidelines for innovation and

The below table contents are derived from project-related websites and referenced accordingly.

decision making

• Research output and white papers
• Clinical guidelines for technology use in care

•
•
•
•
•

entrepreneurship
Utilization of novel clinical tools
Academic outputs, e.g. papers, impact, conference presentations
Number of individuals trained in brain health entrepreneurship
Disciplines of trained individuals
Ecosystem scanning of accelerators and incubators supporting brain health innovation companies

K. Ternes et al.
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value of, BIND. For example, a recent paper
highlighted key issues slowing the pervasive use of
computing technology in aging (Kaye, 2017). Core
issues noted were lack of appreciation for computing
technology providing therapeutic beneﬁts in aging,
lack of evidence-based technologies, and lack of
sustaining investment in the ﬁeld. BIND is uniquely
positioned to understand and integrate these issues,
their business drivers, and current regulations. Such
knowledge will therefore help to optimize the effects
of these platforms on brain health. In Table 3, we
outline these issues and how BIND is uniquely
placed to address them.
Recommendations
To increase the value and practice of BIND, measurable outcomes, training, and education should be
developed and scaled up. We provide the following
recommendations to support the emergence and
growth of this ﬁeld.
INVOLVE

CONSUMERS IN BRAIN HEALTH

INNOVATION DESIGN, RESEARCH, ETHICS,
AND ADVOCACY

Individuals with brain disorders (and those at risk)
should be involved in research, policy, advocacy,
ethics discussions, clinical care, and novel solution
development. This reﬂects Alzheimer Europe’s
position on patient and public involvement (PPI)
in the context of dementia research (Gove et al.,
2018). Novel solution development should focus on
end-user needs, and patients can make valuable
contributions to product design and testing. Validating new technologies prior to implementation
can be difﬁcult through current research practices,
but consumers can help expand research practices
through research prioritization, resource advocacy,
as well as through exploring models for joint clinical
decision making. Patients also have an invaluable
perspective on ethical issues unique to innovative
brain health technologies as both research subjects
and the ultimate beneﬁciaries of new technologies
(Arandjelovic et al., 2019; NSTC, 2019). The deﬁnition of “patients” is evolving as the neurodynamics
of dementia is increasingly shown to begin decades
prior to onset of cognitive decline, implying that
interventions must similarly begin earlier in life and
involve advocacy by healthy at-risk individuals
(Brookmeyer et al., 2018).
CONSTRUCT BIND TRAINING OPPORTUNITIES
Education and training opportunities are critical to
developing the ﬁeld of BIND. These opportunities
must be relevant to the various stakeholders including clinicians, scientists, policymakers, technology
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executives, innovators, philanthropists, and diplomats. Moreover, education and training must be
relevant across the training spectrum from early to
late career. Examples of education and training
could include incorporating innovation into school
curricula, offering fellowship opportunities in
brain health innovation for post-graduate trainees,
and creating certiﬁcate programs for clinicians or
researchers. We propose that to optimally support
BIND, brain health technological innovation and
entrepreneurship engagements should occur in
interdepartmental environments in universities. This
should include departments of neurology, psychiatry,
geriatrics, regulatory science, psychology, sociology,
politics, public policy, public health schools, law
schools, business schools, international studies programs, and design schools. Table 4 outlines potential
methods of incorporating components of BIND into
education programs.
ADVANCE GLOBAL POLICY CHANGE THROUGH
BIND
BIND must actively engage with national and global
policymakers. Building on the strengths and expertise of existing programs and partnerships, there is
an opportunity to become the go-to trusted resource
of knowledge and expertise on all matters related to
brain health innovation to whom policymakers will
turn to during the decision-making process.
A global forum where a consensus of policy ideas
(such as a white paper) is agreed on would be one
possible approach to help facilitate this. Policymakers as well as intragovernmental organizations
(such as the WHO) must be invited to participate in
this forum. The translation of these consensus
recommendations to policymakers is essential to
their implementation and success. Making this connection will require active engagement of the BIND
community. This would include active advocacy to
address the issues identiﬁed within the consensus
agreements. This will help bring recommendations
for brain health innovation to the forefront of
national and global policy agendas. This requires
consensus building and stakeholder engagement so
that a coalition of relevant stakeholders will support
any recommendations made. A visible role within
the policymaking process – as experts, innovators,
and advocates – is needed.
DEVELOP MEASURABLE OUTCOMES TO TRACK
In developing the BIND model, it is critical to also
envisage measurable outcomes to track the value
of the model. In Table 2 and Figure 2, we have
outlined potential measurable outcomes for
BIND projects.
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EXAMPLES OF BRAIN HEALTH
ISSUE

FACTORS SUPPORTING THE DEED FOR AND
DESCRIPTION

V A L U E O F B H IND

.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................

Cybercrime: The yearly cost of cybercrime theft on vulnerable older adults in the USA is
approximately $40 billion (Hall et al., 2016). According to the US Federal Bureau of
Investigation (FBI) (FBI, 2019), many factors contribute to vulnerable older adults
being major targets of cybercriminals. These include:
• Credit history
• Members of a generation that is generally trusting and helpful to others
• Less likelihood of reporting cybercrimes to law enforcement.

Increased cybersecurity education for
vulnerable populations is necessary to
protect those who are vulnerable from
cybercrimes and increase awareness of
suspicious websites (Iyengar et al., 2019).
Increased individual protections for victims
and increased prosecution against
perpetrators are also necessary. Optimized
digital literacy is also key.

Medical data hacking: As electronic technologies in health care are increasingly prevalent
around the world, there are major concerns relating to the security of health care data,
biobank data, and devices. There are many examples of major hacks/breaches of large
health systems and their data. To further complicate matters, there is increased
connectivity to existing computer networks by medical devices, smart phones, hence
creating more cyber vulnerabilities The health care industry is seen as an easier target
for cybercrime given (1) it is a rich source of valuable data and (2) defences are weak
compared to other industries. Breaches and hacks can reduce patient trust, disrupt
health system and their services, and threaten lives (Coventry and Branley, 2018).

Cybersecurity is an integral part of patient
safety and treatment. Legislation and
regulations at the country and global level
are critical to minimizing these risks.

Issues around direct to consumer
genetic testing

Many people worry about Alzheimer’s disease. Physicians often face questions about the
patient’s risk to develop Alzheimer’s disease. The Memory and Aging Center of the
University of California, San Francisco, has developed a report titled “Ordering
Genetic Testing” (MAC, 2017). In this report they outline: “although APOE testing is
clinically available, it is not advised. Direct-to-consumer APOE genotyping is also not advised
(Goldman et al., 2011). APOE is a susceptibility gene, not a deterministic one. If your patient
wishes to pursue APOE genotyping despite recommendations to the contrary, consider referring
to a genetic counselor. Genetic counselors who are knowledgeable about dementia can provide
counseling and education to your patients.” (page 2).

Education is required for clinicians and
consumers alike. Furthermore, regulatory
agencies must be aware of the dynamics in
this market.

Loneliness may reinforce social
media bubbles for older adults

Recently, a review (Ghosh and Iyengar, 2019) demonstrated that “‘lonelier adults exhibit
declines in their ability to self-regulate, a heightened awareness of social threats in their
environment, a greater attention towards negative social stimuli. and a reappraisal of negative
interactions in the service of preserving one’s self esteem’. It then went on to note, “this
constellation of behaviors is noted as seeking to avoid conflict and minimize disappointment,
hence individuals are more likely to source information that mirrors their own worldview
thereby maintaining a sense of self”” (Ghosh and Iyengar, 2019).

Clearly this is an area that requires close
attention and awareness from consumers,
family, social services, and regulatory
agencies.

Cyber issues for older adults

K. Ternes et al.

Downloaded from https://www.cambridge.org/core. Portland State Library, on 21 Jul 2020 at 22:41:47, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
https://doi.org/10.1017/S1041610219002266

Table 3. Complex technological issues justifying the need for and value of Brain health INnovation Diplomacy

EXAMPLES OF BRAIN HEALTH
ISSUE

FACTORS SUPPORTING THE DEED FOR AND
DESCRIPTION

V A L U E O F B H IND

.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................

Lack of privacy policies for health
apps focused on dementia

Little is known about how well these health care applications “apps” protect user healthrelated data. A recent systematic analysis of all iPhone-based apps focused on dementia
revealed significant issues about the privacy policies clarity and the lack of policies
offered (Rosenfeld et al., 2017). Seventy-two apps were found and only 33 (46%) had
an available privacy policy. Nineteen of the 33 with policies (58%) were specific to the
app in question, and 25 (76%) specified how individual user as opposed to aggregate
data would be handled. Among these, authors noted there was a preponderance of
missing information, the majority acknowledged collecting individual data for internal
purposes, and most admitted to instances in which they would share user data with
outside parties.

Increased consumer protections are necessary
to protect patients using dementia apps.
Legislation and regulations at the country
and global level are critical to Improving
privacy policies and hence facilitating more
trust in these apps.

Emergence of cognitive training
digital programs

In 2014, experts from the neurocognition community came together to develop a
consensus on the brain training industry. This work was led by the Max Planck Institute
for Human Development and Stanford Center on Longevity (NASA, 2018). The
consensus stated “We object to the claim that brain games offer consumers a scientifically
grounded avenue to reduce or reverse cognitive decline when there is no compelling scientific
evidence to date that they do. The promise of a magic bullet detracts from the best evidence to
date, which is that cognitive health in old age reflects the long-term effects of healthy, engaged
lifestyles. In the judgment of the signatories below, exaggerated and misleading claims exploit
the anxieties of older adults about impending cognitive decline. We encourage continued careful
research and validation in this field.”

Increased awareness by clinicians and those of
the public that brain training games are not
ultimately solely protective against cognitive
decline. Brain training should be
implemented as part of a healthy mental and
physical lifestyle.

Access to broadband Internet

Many people lack access to reliable internet access across the globe. This is particularly
true of older adults – particularly for those of low socioeconomic status and lower
education levels (PRC, 2014). This is an issue of health equity.
If knowledge, care, services, and interconnections with others – all important ways of
supporting brain health – are increasingly accessed and delivered through the internet
(particularly broadband), but populations at a higher risk of dementia are
disproportionately unable to access it, then this is major technological challenge that
Brain health INnovation Diplomacy could help to mitigate.

Legislation that supports access to broadband
internet particularly for aging populations at
higher risk of developing dementia is both a
national and global policy imperative.

Brain health INnovation Diplomacy
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TARGET OF
EDUCATION

POTENTIAL TO TAILOR TO BRAIN
EXAMPLE OF GENERIC TRAINING PROGRAM

HEALTH INNOVATION DIPLOMACY

..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................

Undergraduate college
students

iDiplomats Program, Innovation Initiative, Massachusetts Institute of Technology’s (MIT) (MIT,
2019): This program involved providing undergraduate students with skills on how to represent MIT
in various international ecosystems, analyze innovation ecosystems, and engage key stakeholders who
can help take innovation from early stages to final products: entrepreneurs, risk capital providers,
government policymakers, universities, and corporations. Participants receive a stipend for travel and
expenses, as well as academic credit. Upon returning to MIT, they write reports on their regions’
innovation ecosystems.
Hacking for Diplomacy, Stanford University (http://web.stanford.edu/class/msande298/): Hacking for
Diplomacy is an undergraduate class that allows students to address real-world foreign policy
challenges by using innovative research and technology methods. Students learn how to apply “Lean
Startup” principles (“Mission Model Canvas”, ”Customer Development,” “Agile Engineering”) to
create and validate agency and user needs to continually build iterative prototypes to test
understanding of the problem and solution. Teams of students use a hands-on approach
that facilitates close engagement with officials in the U.S. State Department and other civilian
agencies.

This program could be tailored to
focus on brain health-related
innovations occurring in various
countries.

Medical students

Psyc 240: Leadership and Innovation in Mental Healthcare, Stanford University (Stanford, 2019):
The country’s first university course on mental health innovation. The course included a diverse
group of students from multiple faculties including Stanford’s School of Medicine, Graduate
School of Business, Law School, School of Engineering, School of Education, and College.
Students learn about mental health, care delivery, technology, and startups. They apply frameworks
to assessing the impact of current innovations and developed their own ideas for solving mental
health problems. They are paired with faculty to improve the clinical validity and marketability
of the idea.

This program could be tailored to
brain health and by also including
international affairs students and
practitioners.

Medical Residency

Digital Health Elective, Yale Department of Psychiatry Adult Residency Program: This course provides
residents an opportunity to explore innovative digital health solutions and their role in clinical care.
Topics range from telepsychiatry and text-based therapy to digital CBT and mobile applications
designed to treat behavioral health diagnoses. By the end of the elective (during the 3-month research
rotation for second-year residents or as a half-day 6 or 12 month course for third-year and fourth-year
residents), residents will produce and submit at least one submission for a peer-reviewed publication
relevant to the field of digital health.

This elective could include global
digital brain health initiatives in its
research to better serve Brain
health INnovation Diplomacy
purposes.
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TARGET OF
EDUCATION

POTENTIAL TO TAILOR TO BRAIN
EXAMPLE OF GENERIC TRAINING PROGRAM

HEALTH INNOVATION DIPLOMACY

..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................

Early Career Academic
Investigators

Psychiatrists,
neurologists,
psychologists and
other brain health
clinicians

This program could be tailored
toward brain health issues

Innovation to Impact Program for Substance Use Researchers at Yale University (http://www.
innovationtoimpact.com): Because substance use is an underserved and heavily stigmatized area of
growing concern, Yale Psychiatry faculty developed a program to help researchers translate their insights
into better clinical treatments for substance use. The program runs an annual innovation bootcamp to
train researchers in the principles of entrepreneurship and innovation. It then provides mentorship and
seed funding to innovators to help them launch substance use innovations that measurably impact patients
struggling with substance use disorder. The program is funded by the National Institute of Drug Abuse
(NIDA).

This program’s curriculum could
further incorporate principles of
BIND by addressing how to
destigmatize substance use in the
eyes of the general public and of
investors.

Recommendations for Value-driven Innovation in Global Mental Health Training, Society for the Study of
Psychiatry and Culture: Developed during an interdisciplinary discussion during the annual meeting
(Kohrt et al., 2016). Priority values included humility, stakeholder engagement, ethical awareness of power
differentials, collaborative action, and “deep accountability” when working in low-resource settings in lowand middle-income countries and high-income countries. Competencies included flexibility and tolerating
ambiguity when working across diverse settings, the ability to systematically evaluate personal biases,
historical and linguistic proficiency, and evaluation skills across a range of stakeholders. Training
experiences included didactics, language training, self-awareness, and supervision in immersive activities
related to professional or academic work.
Atlantic Fellow in Global Brain Health, Global Brain Health Institute, UCSF and Trinity College Dublin
(https://www.gbhi.org/programs): The Atlantic Fellows for Equity in Brain Health program provides
innovative training in brain health, leadership, and dementia risk reduction to a broad array of promising
leaders from various professions, including medicine, science, business, law, journalism, social science,
and the arts. Through their work, fellows are expected to emphasize local and global health inequities that
need to be addressed by practitioners and policymakers, with the goal of transforming local communities
around the world. Atlantic Fellows join the program for 12 months and have a base at the University of
California, San Francisco or Trinity College Dublin. A core curriculum of weekly courses in economics,
epidemiology, law and ethics, leadership, neuroscience, public policy, and statistics constitutes part of the
experience. They also have opportunities to work with individuals with cognitive disorders.
Leadership in Mental Health Short Course, Sangath Institute, Goa, India (http://www.sangath.in): The
Leadership in Mental Health (LMH) course aims to equip participants with methods to develop and
scale-up interventions for mental health in resource-constrained settings. It also aims to augment
leadership skills needed to scale-up mental health care programs and promote the human rights of people
with mental illness. The course has been widely accepted globally, and since its inception, over 400
participants from around the world, including Nepal, Afghanistan, Sri Lanka, Vietnam, Cambodia,
Germany, United States, Canada, Japan, Brazil, Peru, China, Zambia, Liberia, and Kenya have attended
the course.

These programs could be tailored to
focus on brain health (which
GBHI is) and by including
extensive entrepreneurship and
innovation diplomacy teachings.
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Science Diplomacy Dialogue Series, Science Diplomacy Center, The Fletcher School, Tufts University
(Tufts University, 2019): The diplomacy dialogue series includes discussions on Globally Interconnected
Civilization, Informed Decision Making for Sustainability, The Arctic Case Study, Capstone Project
Enhancement with Holistic Integration. The series aims to educate on theory and practice of science
diplomacy and participate in discussions about how to incorporate both natural and social sciences into
foreign policy decision making and international negotiations.

Brain health INnovation Diplomacy
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Corporations

Johnson & Johnson Mental Health Diplomats Program (https://www.jnj.com/tag/mental-health-diplomats):
Founded in April 2017, the Mental Health Diplomats Program was initially conceived to help reduce
workplace mental health stigma and creative a supportive workplace environment through personal
empowerment programs and leadership trainings for employees of Johnson & Johnson. It has since
become one of the fastest growing new employee resource groups with over 1000 employees in 32
countries and over 350 trained in mental health first aid. Johnson & Johnson has since gone on to cofound
citiesRISE, which is a global platform dedicated to changing the state of mental health care policy and
practice to better serve the needs of populations across the world.

These programs could be tailored to
focus on brain health.

General Programs

MIT Hacking Mediicne (http://hackingmedicine.mit.edu/): The Massachusetts Institute of Technology
Hacking Medicine (MIT HM) team is a student, academic, and community-led group that developed and
pioneered the hackathon methodology in 2012 specifically for health, using systems-oriented design
thinking to address challenges in health and medicine 30. The MIT HM methodology has employed this
process toward over 100 events in over 20 countries in both low-resource and high-resource settings and
continuously refined this methodology over the past 6 years. Over the past 6 years, over 40 companies have
been created out of HM events, collectively raising over $150M in funding. An MIT HM hackathon
comprises four stages: (1) problem identification, (2) team formation, (3) solution conception, and (4)
iteration and implementation.

These programs could be tailored to
focus on brain health.

The below table contents are derived from project-related websites and referenced accordingly.
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• Number of investigators trained in innovation diplomacy, innovation and
entrepreneurship
• Countries where invested companies are headquartered
• Clinical tools developed and scaled into the market
• Readership and utilization of guidelines for innovation and entrepreneurship
• Ecosystem scanning of accelerators and incubators supporting brain health
innovation companies
• Numbers of multi-national projects initiated and completed
• Contributions for funding of foreign governments and foreign owned nonprofits and
for profit corporations
• Demographic changes in brain health behaviors

Figure 2. Potential Measurable Outcomes of Brain health INnovation Diplomacy-Related Activities.

Conclusions
BIND is a novel model that, if operationalized
effectively, can bring about positive changes through
its role in economic and cultural inﬂuence. The ﬁeld
will continue to grow in importance as advances in
data analytics, “omic” analyses, and more ubiquitous and affordable use of smart devices are coupled
with increasing globalization and decreasing brain
health stigma in the modern world.
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